2.50K
·
2025-10-03
$AMD 20260320 200.0 CALL$ patience has really paid off!! There's a period of range bound for days and down down down until I have an urge to cut loss.. but my long term bullish conviction in AMD convinced me to held on n now it's really turning on the bulls and on 🔥!!!
TOPMerle Ted: IMHO, AMD needs to learn how to play nice with other companies. I believe that is some of the reason why we see NVDIA and INTC doing so well. They are out look for partners. AMD appears to feel they will do everything themselves.
1.14K
1.08K
·
2025-10-03
$Garmin(GRMN)$ up 1K for coins! They are getting sued by strava which while I think it is a joke its shouldn't affect them . Love their products as the battery life is long and has lots of other useful features such as torchlight and sleep tracking .
TOPI kind of hope this drops to below $200 but I’m a buyer below $210. This is a great company with few real competitors.
739
·
2025-10-03
$Taiwan Semiconductor Manufacturing(TSM)$
TOPThanks for your sharing!
1.12K
·
2025-10-03
$CapLand IntCom T(C38U.SI)$ is now the largest Reit in Asia [Happy]
TOPIt really has long-term investment value.
31.17K
·
2025-10-03
$Rigetti Computing(RGTI)$ WHAT A MONTH FOR RIGETTI!! After gaining almost 150% in the past month and riding the quantum computing wave, I have finally decided to close off my position in Rigetti, realising a profit of USD 92k! Truly insane!
TOPThey proceeded to smash Friday’s trading with another 13% during trading hours
2.19K
·
2025-10-02
$INCANNEX HEALTHCARE LTD(IXHL)$ If the IXHL discovered an oral cure for chronic obstructive sleep apnea (OSA), the impact would be enormous—medically, socially, and economically. Here’s how it might play out: 🌍 Medical Impact 1. End of CPAP dependency – Millions of patients would no longer need to use CPAP machines or other invasive devices every night. 2. Reduced surgeries – Procedures like UPPP (uvulopalatopharyngoplasty), jaw advancement, or hypoglossal nerve stimulation would see a huge decline. 3. Better overall health – Untreated OSA contributes to hypertension, heart disease, stroke, diabetes, and even dementia. A cure could lower risks across all of these. 4. Sleep quality revolution – Millions would finally get restorative sleep, re
TOPResMed’s $13B CPAP revenue’d crash—this is a existential threat for them!
1.05K
·
2025-10-02
SIA dividend play on falling interest Cash Boost Lucky Draw
Find out more here: Cash Boost Lucky Draw Hey friend! Tap to help me out and get a mystery gift for yourself—check it out now! Why I’m Buying SIA at $6.52: A Long-Term Investment with Dividend Sweetness ✈️💰 Buying at a Strategic Price Point I am buying Singapore Airlines (SIA) at $6.52 because the price aligns with strong technical and fundamental considerations. Historically, SIA has experienced fluctuations due to seasonal travel demand, oil prices, and global economic factors, but $6.50–$6.60 has proven to be a support zone in recent t
TOPSIA’s $6.52 entry hits support—dividends here make downside small!
1.28K
·
2025-10-02
Tiger Weekly Insights: 2025/09/22—2025/09/28
I. Performance of Global Equity Indices (in US Dollar) Source: Bloomberg, Tiger Brokers Key Highlights ◼ Last week, Chair Powell openly noted that U.S. equity valuations appear stretched, triggering a short-term pullback. Nonetheless, macro fundamentals and earnings continue to provide a floor. Q2 GDP was revised up to 3.8%, while August core PCE came in at 2.9% YoY—evidence of economic resilience and contained inflation. Labor market cooling has had limited impact in the context of a rate-cutting cycle, allowing the “Goldilocks” narrative to persist. Consumption remains broadly stable but increasingly reliant on high-income households, with weak sentiment among low-income families posing medium-term risks. On the earnings side, demand from AI continues to drive recovery, with S&P 500
TOPImpressive insights and a great analysis!
1.09K
·
2025-10-02
Intel, Opendoor, Tesla, SMCI, Rocket, Nike Saw Rising Short Volume Intel saw the biggest increase in trading of borrowed shares that were sold short as the stock almost doubled from its low in April, raising the risk of a squeeze for speculators that bet against the legacy semiconductor company. $Opendoor Technologies Inc(OPEN)$
TOPIntel’s $8.87B US govt cash + AMD talks—short squeeze’s gonna be brutal!
1.22K
·
2025-10-02
Pfizer's 14+% Rally This Week Weakens Case for Put Options $Pfizer(PFE)$
TOPOn the weekly chart it was up about 4$ with the highest volume 0f 495 million shares. Highest since April 2016. That’s over 9 years. That’s a high conviction from buyers. Easy to hit 30$ or higher soon.
1.73K
·
2025-10-02
Why I Buy OCBC at $16.54: A Retirement Dividend Play 💰🏦 Cash Boost Lucky Draw
Find out more here: Cash Boost Lucky Draw Hey friend! Tap to help me out and get a mystery gift for yourself—check it out now! Why I Buy OCBC at $16.54: A Retirement Dividend Play 💰🏦 I chose to buy OCBC shares at around $16.54, and now the price has moved slightly to $16.76, giving a small capital gain. Beyond short-term movements, my primary focus is dividend income, which is around $1 per share per year. For me, OCBC is more than a stock — it’s a retirement dividend fund. By accumulating shares steadily over time, I aim to build a relia
1.31K
·
2025-10-02
$Alibaba(BABA)$ $Baidu(BIDU)$ $JD.com(JD)$ 🚀🔥 Alibaba’s $320 Roadmap: Golden Week, Burry, and the New China AI Ecosystem 🔥🚀 I am convinced Alibaba has just re-entered a multi-year expansion cycle, and the market is only beginning to price in the scale of its consumer, AI, and ecosystem dominance. This is no longer about recovery trades; it is about leadership. 📍 Golden Week Data Proves Ecosystem Power $BABA Amap (China’s Google Maps) hit a record 360M daily users on Day 1 of Golden Week 🇨🇳🎉. Its AI assistant processed 2.6B requests, delivered 290M safety alerts, and boosted local restaurants. This isn’t a one-off spike; it’s embedded infrastructure in China’s most
TOPI’m struck by how Amap’s 360M daily users feed directly into Alibaba’s broader AI loop. That scale of real-time data is exactly what makes me think of NVDA’s data center edge, but applied domestically in China. BABA’s $320 roadmap feels structurally credible.
2.36K
·
2025-10-02
My greatest mistakes are as follow:- 1. Averaging down without a plan — Buying more to recover losses can actually amplify risk. 2. Letting small losses turn into disasters — Small losses that are ignored can wipe out your account. 3. No stop loss, or moving stops — Losses can snowball uncontrollably. 4. Holding on to “it will rebound” hope — Gambling on luck instead of following rules often ends badly. 5. Ego as I do not want to sell at loss. I always think I am buying a share for earning profit and not at loss, so I will hold on to it till it make profit before I decided to sell off. As a result, I can end up the share become zero value due to delisting. However, all these mistakes still never change my trading habits. I never regretted holding on to the shares like
TOPI will hold BABA until my Grandchildren are very rich.................
1.33K
·
2025-10-03
$Tesla Motors(TSLA)$ $T-REX 2X INVERSE TESLA DAILY TARGET ETF(TSLZ)$ $YIELDMAX TSLA OPTION INCOME STRATEGY ETF(TSLY)$ 🚀⚡🔮 Tesla Compression Test: $TSLA Balances on Razor Edge at $448.80 🚀⚡🔮 I’m looking at Tesla with the conviction of a Wall Street strategist, and I see price locked in a compression test where one misstep decides whether bulls or bears seize control. 📉 Support Stability Zones 🔵 $448.80 is the current red mid-line pivot where balance hangs. 🔵 $440.27 sits just below as a cyan stability marker. 🔵 Lower band demand zone at $437–$433 is where deeper liquidity pools wait to catch falling price. 📈 Resistance & Danger Ceilings 🔴 $446.30 is the gold E
TOPI like how you tied the Q3 deliveries beat with the options surface. That $85M in call dumping is serious positioning. Reminds me of what happened in $NVDA when everyone hedged downside right before it ripped.
1.91K
·
2025-10-03
$Taysha Gene Therapies, Inc.(TSHA)$ $NEUROGENE INC(NGNE)$ $Sarepta Therapeutics(SRPT)$ 📊🧬🚀 $TSHA Biotech Breakout: Gene Therapy Catalyst Ignites 40%+ Surge 📊🧬🚀 I’m tracking $TSHA as it becomes the standout small-cap mover today, ripping over 40% after receiving FDA Breakthrough Therapy Designation for TSHA-102 in Rett syndrome. This is the same setup we’ve seen before: historically, every time $TSHA has gapped 30%+ on news, it’s gone on to close higher by 100% on 4 prior occasions. Today’s intraday action is mirroring that pattern, with price holding above support. 🧩 Catalyst: FDA alignment on pivotal trial pathway, validating the program. This is critical in bio
TOPWhat stands out is the volume spike confirmation. When I see liquidity build like this on $TSHA it feels more real than a one-off headline pop. The way you mapped the $5 resistance reminds me of how $BIIB struggled until it cleared a major FDA inflection!
1.43K
·
2025-10-03
$Tesla Motors(TSLA)$ $TSLA 450 has become a masterclass in market relativity. Yesterday it looked like a victory lap on the way to new highs, today it feels like gravity testing conviction. Harmonic symmetry has already played out; what comes next is either the birth of a textbook handle that matures into a larger cup formation or the kind of liquidity flush that sends price hunting the $441–446 demand pocket. I trimmed on the euphoric $479 spike and now I’m waiting to see whether this zone proves structural or just another mirage in Tesla’s long tradition of head-fakes. The irony: same price, entirely different psychology. 📢 Don’t miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets 🚀📈 I’m
TOPThat $479 pop then straight slide feels like Tesla’s signature fakeout move. If we hold $441–446 and build higher lows, this could set up for a monster swing. Love how you trimmed and now wait for structure confirmation 🧃
1.02K
·
2025-10-03
02 Oct Market Closed Record Highs As U.S. Government Shutdown Concerns Is Shrugged Off
We saw on Thursday (02 October), the three leading U.S. indexes closed at record highs, this is because investors shrugged off concerns tied to a U.S. government shutdown that had entered its second day. Here is a summary of what happened in U.S. markets on Thursday, October 2, 2025 (the second day of the month / second trading day) — major moves, drivers, and standout gainers & losers: Market Performance & Context Index Moves / Summary The S&P 500 rose modestly by ~0.06 % to 6,715.35, closing at a record high. The Dow Jones Industrial Average gained ~0.17 % to 46,519.72 (also a record close) The Nasdaq Composite led the gains, up ~0.39 % (or ~0.4 %) to 22,844.05 On the small-cap front, the Russell 2000 also advanced (~0.7 %) to about 2,458.49 Despite headwinds from a U.S. gove
TOPMSFT is lying about their depreciation costs. Their profits are fake. $30billion CAPEX a quarter is $8 billion in depreciation per quarter for data centers.
396
·
2025-10-03
Global Stocks Rally Despite US Shutdown Concerns
Market Overview Global equities closed higher on October 2, 2025, with US and European benchmarks hitting fresh record highs as investors looked past the ongoing US government shutdown. Optimism over potential US rate cuts and resilience in industrials and tech-related shares supported overall sentiment, while Asia tracked the positive momentum. US: Records Amid Shutdown Wall Street extended its rally, with the Dow Jones $DJIA(.DJI)$
966
·
2025-10-03
Constellation Brands (STZ) Earnings To Show Impact From Challenging Macroeconomic
$Constellation(STZ)$ is expected to report its fiscal Q2 2026 earnings report on 06 October 2025 after market close. The upcoming Q2 2026 earnings for Constellation Brands is likely to be a highly scrutinized report, following a challenging Q1 and a subsequent downward revision to the full-year guidance in September 2025. Investor sentiment appears cautious, with the stock significantly underperforming the broader market over the last six months. Comparable EPS: EPS is expected to come in between ≈$3.37 to $3.42 which represent ≈−22% to −25% YoY Change (Approx.), this is sharp decline from $4.32 in Q2 FY25. Total Revenue: revenue is expected to come in between ≈$2.46 to $2.68 billion which is ≈−8% to −16
TOPSTZ’s Pacifico growth + inventory rebalancing—beer segment can weather the headwinds!